Kanes Foods

Installation overview


Worcestershire, UK

Commissioned / installed date:


Technology configuration used:

Multitube / Multichannel

MBR technology / membrane product used:

Aquabio Ltd AMBR LE

Scale of installation:

Small-scale industrial

Capacity range MLD:


0.82 MLD

Primary consultant / contractor:

Aquabio Ltd

Installation owned by:

Kanes Foods

About Kanes Foods

The plant is an example of food effluent recycling with a sidestream pumped MBR based on Aquabio’s “AMBR” technology, and was commissioned in 2001. 80% of the flow is recycled.

The process treatment scheme comprises upstream screening, flow balancing, DAF treatment (for fine vegetable solids removal), the MBR itself and downstream treatment by reverse osmosis followed by UV disinfection. The permeate water is blended with mains water for use within the factory. The MBR comprises two 250 m3 bioreactors with four banks of crossflow membrane modules. The maximum MLSS concentration employed has been 20 g/L, but the bioreactor is generally operated at around 10 g/L resulting in food-to-micro-organism (F:M) ratios of around 0.13 kg COD/kg MLSS day.

Sludge production is calculated as being 0.14 kg DS/kg COD removed from a sludge age of over 100 days. Each membrane bank is fitted with four 200 mm diameter MT UF Norit membranes. The membranes operate at an average flux of 153 LMH normalised to 25°C. The permeate water has average TSS, BOD and COD concentrations of 4, 7 and 16 mg/L respectively. The UF permeate is passed to a two-stage reverse osmosis plant which achieves an overall recovery of 75-80%. The reject stream is discharged to sewer and the permeate, which typically has a conductivity of 40-100 µS/cm, is passed to the UV disinfection unit and then to the client’s water supply tank.

The plant has performed consistently in terms of biological treatment, membrane performance and final reuse water quality. For the majority of the time membrane performance has been better than design, allowing one bank to be maintained as a standby and so offering greater process flexibility and lower energy use. Occasional reductions in membrane flux have been linked to poor biomass health which has been rectified by closer management of the process.

Image gallery

More information

Information on this page has been supplied by third parties and is not necessarily endorsed by The MBR Site. You must contact the third parties to confirm information is accurate and complete before acting upon it. The MBR Site accepts no responsibility for any action taken or costs incurred as a result of information on The MBR Site. The MBR Site accepts no responsibility for the content of third party websites. Any views expressed are those of the third parties and do not necessarily reflect the views of The MBR Site.

‘The MBR Site’ is a trading division of Judd and Judd Ltd, a company registered in England and Wales, registered number 8082403.

Registered office: Suite 2, Douglas House, 32-34 Simpson Road, Fenny Stratford, Buckinghamshire, MK1 1BA, United Kingdom. Email: info@thembrsite.com

Banner image: full treatment plant for pharmaceutical wastewater in Taizhou, Linhai Park, Zhejiang Province, China, including Shanghai MEGAVISION  flat sheet UF membrane modules in two MBR units. Image courtesy of VALORSABIO, Lda.

Image credits:

– Image for our Chinese largest plants 全球最大的MBR项目 homepage link: Image supplied by Apex Environmental
– Image for our Consultants and Contractors homepage link: Image supplied by Ovivo USA, LLC.

Disclaimer: The information given on this website is reproduced in good faith. No liability is accepted for errors or omissions. The MBR Site does not endorse any products, services, organisations, events or any other listing included in this site. You are strongly advised to check all information, including specifications and installation details, before acting on any information given in this website. The MBR Site links to third-party websites – note that we are not responsible for the content of third-party websites and third-party websites are visited at your own risk. Please read our terms and conditions and privacy policy. Use of this website indicates acceptance of these conditions.

This website is designed for modern browsers – if you have problems viewing our website, you may wish to upgrade your browser.